These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35212542)

  • 41. 8-(Furan-2-yl)-3-phenethylthiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thione as novel, selective and potent adenosine A(2A) receptor antagonist.
    Kumari N; Mishra CB; Prakash A; Kumar N; Mongre R; Luthra PM
    Neurosci Lett; 2014 Jan; 558():203-7. PubMed ID: 24161891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel approaches for targeting the adenosine A2A receptor.
    Yuan G; Gedeon NG; Jankins TC; Jones GB
    Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy.
    Giuffrida L; Sek K; Henderson MA; Lai J; Chen AXY; Meyran D; Todd KL; Petley EV; Mardiana S; Mølck C; Stewart GD; Solomon BJ; Parish IA; Neeson PJ; Harrison SJ; Kats LM; House IG; Darcy PK; Beavis PA
    Nat Commun; 2021 May; 12(1):3236. PubMed ID: 34050151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of adenosine receptors in the human bladder carcinoma T24 cell line.
    Phelps PT; Anthes JC; Correll CC
    Eur J Pharmacol; 2006 Apr; 536(1-2):28-37. PubMed ID: 16581066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer.
    Ferré S; Bonaventura J; Tomasi D; Navarro G; Moreno E; Cortés A; Lluís C; Casadó V; Volkow ND
    Neuropharmacology; 2016 May; 104():154-60. PubMed ID: 26051403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adenosine receptor subtypes mediating coronary vasodilation in rat hearts.
    Hinschen AK; Rose'Meyer RB; Headrick JP
    J Cardiovasc Pharmacol; 2003 Jan; 41(1):73-80. PubMed ID: 12500024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of 5'-N-ethylcarboxamidoadenosine on evoked release of [3H]serotonin in the rat nucleus tractus solitarius.
    Helfman CC; Zhong H; Barraco RA; Anderson GF
    Neurosci Lett; 1996 Jul; 213(1):61-5. PubMed ID: 8844713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A2A adenosine receptor protects tumors from antitumor T cells.
    Ohta A; Gorelik E; Prasad SJ; Ronchese F; Lukashev D; Wong MK; Huang X; Caldwell S; Liu K; Smith P; Chen JF; Jackson EK; Apasov S; Abrams S; Sitkovsky M
    Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13132-7. PubMed ID: 16916931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cancer-Associated Mutations of the Adenosine A
    Feng C; Wang X; Jespers W; Liu R; Zamarbide Losada SD; Gorostiola González M; van Westen GJP; Danen EHJ; Heitman LH
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35897852
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological characterization of adenosine A2B receptors: studies in human mast cells co-expressing A2A and A2B adenosine receptor subtypes.
    Feoktistov I; Biaggioni I
    Biochem Pharmacol; 1998 Mar; 55(5):627-33. PubMed ID: 9515573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenosine A2a receptors increase arterial endothelial cell nitric oxide.
    Li Jm; Fenton RA; Wheeler HB; Powell CC; Peyton BD; Cutler BS; Dobson JG
    J Surg Res; 1998 Dec; 80(2):357-64. PubMed ID: 9878338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxygenation and A2AR blockade to eliminate hypoxia/HIF-1α-adenosinergic immunosuppressive axis and improve cancer immunotherapy.
    Halpin-Veszeleiova K; Hatfield SM
    Curr Opin Pharmacol; 2020 Aug; 53():84-90. PubMed ID: 32841869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intranasal administration of NECA can induce both anti-inflammatory and pro-inflammatory effects in BALB/c mice: evidence for A 2A receptor sub-type mediation of NECA-induced anti-inflammatory effects.
    El-Hashim AZ; Abduo HT; Rachid OM; Luqmani YA; Al Ayadhy BY; Alkhaledi GM
    Pulm Pharmacol Ther; 2009 Jun; 22(3):243-52. PubMed ID: 19146972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New 8-substituted xanthiene derivatives as potent bronchodilators.
    Berk B; Akgün H; Erol K; Sirmagül B; Gao ZG; Jacobson KA
    Farmaco; 2005; 60(11-12):974-80. PubMed ID: 16243321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Toll-like receptors, NF-κB, and IL-27 mediate adenosine A2A receptor signaling in BTBR T
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):184-191. PubMed ID: 28668513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NF-κB enhances hypoxia-driven T-cell immunosuppression via upregulation of adenosine A(2A) receptors.
    Bruzzese L; Fromonot J; By Y; Durand-Gorde JM; Condo J; Kipson N; Guieu R; Fenouillet E; Ruf J
    Cell Signal; 2014 May; 26(5):1060-7. PubMed ID: 24486403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histamine H3 receptor activation counteracts adenosine A2A receptor-mediated enhancement of depolarization-evoked [3H]-GABA release from rat globus pallidus synaptosomes.
    Morales-Figueroa GE; Márquez-Gómez R; González-Pantoja R; Escamilla-Sánchez J; Arias-Montaño JA
    ACS Chem Neurosci; 2014 Aug; 5(8):637-45. PubMed ID: 24884070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of adenosine A2A and A2B receptors in the regulation of TNF-alpha production by human monocytes.
    Zhang JG; Hepburn L; Cruz G; Borman RA; Clark KL
    Biochem Pharmacol; 2005 Mar; 69(6):883-9. PubMed ID: 15748700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microglia.
    Gomes C; Ferreira R; George J; Sanches R; Rodrigues DI; Gonçalves N; Cunha RA
    J Neuroinflammation; 2013 Jan; 10():16. PubMed ID: 23363775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and Evaluation of Phenylxanthine Derivatives as Potential Dual A2AR Antagonists/MAO-B Inhibitors for Parkinson's Disease.
    Wang X; Han C; Xu Y; Wu K; Chen S; Hu M; Wang L; Ye Y; Ye F
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28629145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.